These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3830955)

  • 21. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost containment of the second-generation cephalosporins by prospective monitoring at a community teaching hospital.
    Williams RR; Gross PA; Levine JF
    Arch Intern Med; 1985 Nov; 145(11):1978-81. PubMed ID: 4062447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of the biliary excretion of some chemotherapeutic agents in patients with biliary disease].
    Basoli A; Fiocca F; Pierini N; Schietroma M; Pianese G; Sgambati P; Giovannone D; Speranza V
    Ann Ital Chir; 1989; 60(2):129-32; discussion 133. PubMed ID: 2817651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum and tissue concentrations of cefoxitin and cefamandole in women undergoing hysterectomy.
    French MA; Quintiliani R; Nightingale CH; Russo JN
    Obstet Gynecol; 1983 Jan; 61(1):42-7. PubMed ID: 6823348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New rapid method of analysis of cefoxitin in serum and bone, by high-performance liquid chromatography.
    Purser C; Baltar A; Ho IK; Hume AS
    J Chromatogr; 1984 Nov; 311(1):135-40. PubMed ID: 6520154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excretion of cefamandole in the bile.
    Lindahl F; Kjaer TB; Thomsen VF
    Scand J Infect Dis Suppl; 1980; suppl 25():58-9. PubMed ID: 6937953
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cefamandole- and cefoxitin-produced changes in drug sensitivity of Escherichia coli].
    Jastalska D; Lupicki W; Zapaśnik M; Pajchel G; Chojnowski W
    Pol Tyg Lek; 1988 Dec; 43(49):1576-9. PubMed ID: 3076651
    [No Abstract]   [Full Text] [Related]  

  • 28. Liquid-chromatographic assay of cefamandole in serum, urine, and dialysis fluid.
    Bliss M; Mayersohn M
    Clin Chem; 1986 Jan; 32(1 Pt 1):197-200. PubMed ID: 3940707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ampicillin versus cefamandole in biliary tract surgery. A prospective, randomized clinical and bacteriological study.
    Levi JU; Martinez OV; Hutson DG; Livingstone A; Zeppa R; Malinin TI; Einhorn N
    Am Surg; 1984 Aug; 50(8):412-7. PubMed ID: 6380362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefamandole versus cefoxitin prophylaxis in patients undergoing cholecystectomy.
    Dougherty SH; Saltzstein EC; Peacock JB; Mercer LC
    Am Surg; 1988 Aug; 54(8):495-9. PubMed ID: 3395027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG; Gauvreau L; Nguyen BM
    Scand J Infect Dis Suppl; 1980; suppl 25():60-5. PubMed ID: 6937954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of cefotaxime versus cefamandole in prophylaxis for surgical treatment of the biliary tract.
    Wilson SE; Hopkins JA; Williams RA
    Surg Gynecol Obstet; 1987 Mar; 164(3):207-12. PubMed ID: 3103245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retained common bile duct stones after endoscopic sphincterotomy: temporary and longterm treatment with biliary stenting.
    Kochlef A; Gargouri D; Kilani A; Ouakaa A; Elloumi H; Kharrat J; Belhadj N; Romani M; Ghorbel A
    Tunis Med; 2011 Apr; 89(4):342-6. PubMed ID: 21484682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-pancreatic juice barrier to antibiotic excretion.
    Burns GP; Stein TA; Kabnick LS
    Am J Surg; 1986 Feb; 151(2):205-8. PubMed ID: 3946753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of free fatty acids in the formation of cholelith].
    Wang ZY
    Zhonghua Wai Ke Za Zhi; 1992 Feb; 30(2):91-3, 125. PubMed ID: 1395972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A pharmacokinetic study of diffusion in adenomatous prostatic tissue of an intravenous bolus of cefamandole].
    Billebaud T; Astier L; Rutkowski A; Boccon-Gibod L
    Ann Urol (Paris); 1990; 24(2):141-5. PubMed ID: 1693483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention of infection after biliary surgery in high risk patients].
    Ronconi P; Giovannini I; Civello IM; Borzone A; Nanni G; Gui D
    Chir Patol Sper; 1981 Oct; 29(5):241-5. PubMed ID: 7052795
    [No Abstract]   [Full Text] [Related]  

  • 39. An on-line, column-switching high-performance liquid chromatographic procedure for the removal of probenecid from human plasma, serum, or urine in the quantitative determination of cefmetazole or cefoxitin.
    Bothwell WM; Cathcart KS; Bombardt PA
    J Pharm Biomed Anal; 1989; 7(8):987-95. PubMed ID: 2490108
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of cefamandole in osseous tissue.
    Lunke RJ; Fitzgerald RH; Washington JA
    Antimicrob Agents Chemother; 1981 May; 19(5):851-8. PubMed ID: 7294769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.